Maximizing the utility of a single site randomized controlled psychotherapy trial

Sonya B Norman, Moira Haller, Andrea D Spadoni, Sean Patrick Andrews Drummond, Victoria B Risbrough, Jessica L Hamblen, Ryan S Trim, Erika X Blanes

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Purpose of the research: There is increasing interest in including measures of biological mechanisms as mediators and moderators of treatment outcome in randomized controlled trials (RCT s) of psychotherapy efficacy. However, examining biological mechanisms is often expensive and budget caps of most major funding agencies have remained stable in recent years. The goal of this manuscript is to describe how a psychotherapy efficacy trial is using a model of collaborative, affiliated grants to maximize resources and the potential knowledge to be gained from a single site RCT.Principal results and conclusions: The trial is an ongoing RCT comparing two psychotherapies for the treatment of concurrent posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) with a sample of treatment seeking veterans. Through collaboration with a team of investigators with independently-funded but affiliated grants, measures of select sleep, neurobiological, and genetic biomarkers were integrated into this single site RCT. This model has allowed us to pose research questions regarding the role of biological mechanisms, maximize the utility of recruitment, and be efficient in maximizing knowledge to be gained in a way that would not be possible solely on the funding of a single site RCT. Challenges of this model include high participant burden in regard to assessment and complicated coordinating procedures among studies. Strategies to address these challenges are described
Original languageEnglish
Pages (from-to)244 - 251
Number of pages8
JournalContemporary Clinical Trials
Volume42
DOIs
Publication statusPublished - 2015

Cite this

Norman, S. B., Haller, M., Spadoni, A. D., Drummond, S. P. A., Risbrough, V. B., Hamblen, J. L., ... Blanes, E. X. (2015). Maximizing the utility of a single site randomized controlled psychotherapy trial. Contemporary Clinical Trials, 42, 244 - 251. https://doi.org/10.1016/j.cct.2015.04.011
Norman, Sonya B ; Haller, Moira ; Spadoni, Andrea D ; Drummond, Sean Patrick Andrews ; Risbrough, Victoria B ; Hamblen, Jessica L ; Trim, Ryan S ; Blanes, Erika X. / Maximizing the utility of a single site randomized controlled psychotherapy trial. In: Contemporary Clinical Trials. 2015 ; Vol. 42. pp. 244 - 251.
@article{47522c3e065d4fed92086541b09dd322,
title = "Maximizing the utility of a single site randomized controlled psychotherapy trial",
abstract = "Purpose of the research: There is increasing interest in including measures of biological mechanisms as mediators and moderators of treatment outcome in randomized controlled trials (RCT s) of psychotherapy efficacy. However, examining biological mechanisms is often expensive and budget caps of most major funding agencies have remained stable in recent years. The goal of this manuscript is to describe how a psychotherapy efficacy trial is using a model of collaborative, affiliated grants to maximize resources and the potential knowledge to be gained from a single site RCT.Principal results and conclusions: The trial is an ongoing RCT comparing two psychotherapies for the treatment of concurrent posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) with a sample of treatment seeking veterans. Through collaboration with a team of investigators with independently-funded but affiliated grants, measures of select sleep, neurobiological, and genetic biomarkers were integrated into this single site RCT. This model has allowed us to pose research questions regarding the role of biological mechanisms, maximize the utility of recruitment, and be efficient in maximizing knowledge to be gained in a way that would not be possible solely on the funding of a single site RCT. Challenges of this model include high participant burden in regard to assessment and complicated coordinating procedures among studies. Strategies to address these challenges are described",
author = "Norman, {Sonya B} and Moira Haller and Spadoni, {Andrea D} and Drummond, {Sean Patrick Andrews} and Risbrough, {Victoria B} and Hamblen, {Jessica L} and Trim, {Ryan S} and Blanes, {Erika X}",
year = "2015",
doi = "10.1016/j.cct.2015.04.011",
language = "English",
volume = "42",
pages = "244 -- 251",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier",

}

Norman, SB, Haller, M, Spadoni, AD, Drummond, SPA, Risbrough, VB, Hamblen, JL, Trim, RS & Blanes, EX 2015, 'Maximizing the utility of a single site randomized controlled psychotherapy trial', Contemporary Clinical Trials, vol. 42, pp. 244 - 251. https://doi.org/10.1016/j.cct.2015.04.011

Maximizing the utility of a single site randomized controlled psychotherapy trial. / Norman, Sonya B; Haller, Moira; Spadoni, Andrea D; Drummond, Sean Patrick Andrews; Risbrough, Victoria B; Hamblen, Jessica L; Trim, Ryan S; Blanes, Erika X.

In: Contemporary Clinical Trials, Vol. 42, 2015, p. 244 - 251.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Maximizing the utility of a single site randomized controlled psychotherapy trial

AU - Norman, Sonya B

AU - Haller, Moira

AU - Spadoni, Andrea D

AU - Drummond, Sean Patrick Andrews

AU - Risbrough, Victoria B

AU - Hamblen, Jessica L

AU - Trim, Ryan S

AU - Blanes, Erika X

PY - 2015

Y1 - 2015

N2 - Purpose of the research: There is increasing interest in including measures of biological mechanisms as mediators and moderators of treatment outcome in randomized controlled trials (RCT s) of psychotherapy efficacy. However, examining biological mechanisms is often expensive and budget caps of most major funding agencies have remained stable in recent years. The goal of this manuscript is to describe how a psychotherapy efficacy trial is using a model of collaborative, affiliated grants to maximize resources and the potential knowledge to be gained from a single site RCT.Principal results and conclusions: The trial is an ongoing RCT comparing two psychotherapies for the treatment of concurrent posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) with a sample of treatment seeking veterans. Through collaboration with a team of investigators with independently-funded but affiliated grants, measures of select sleep, neurobiological, and genetic biomarkers were integrated into this single site RCT. This model has allowed us to pose research questions regarding the role of biological mechanisms, maximize the utility of recruitment, and be efficient in maximizing knowledge to be gained in a way that would not be possible solely on the funding of a single site RCT. Challenges of this model include high participant burden in regard to assessment and complicated coordinating procedures among studies. Strategies to address these challenges are described

AB - Purpose of the research: There is increasing interest in including measures of biological mechanisms as mediators and moderators of treatment outcome in randomized controlled trials (RCT s) of psychotherapy efficacy. However, examining biological mechanisms is often expensive and budget caps of most major funding agencies have remained stable in recent years. The goal of this manuscript is to describe how a psychotherapy efficacy trial is using a model of collaborative, affiliated grants to maximize resources and the potential knowledge to be gained from a single site RCT.Principal results and conclusions: The trial is an ongoing RCT comparing two psychotherapies for the treatment of concurrent posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) with a sample of treatment seeking veterans. Through collaboration with a team of investigators with independently-funded but affiliated grants, measures of select sleep, neurobiological, and genetic biomarkers were integrated into this single site RCT. This model has allowed us to pose research questions regarding the role of biological mechanisms, maximize the utility of recruitment, and be efficient in maximizing knowledge to be gained in a way that would not be possible solely on the funding of a single site RCT. Challenges of this model include high participant burden in regard to assessment and complicated coordinating procedures among studies. Strategies to address these challenges are described

UR - http://ac.els-cdn.com/S1551714415000828/1-s2.0-S1551714415000828-main.pdf?_tid=eef2d672-47ba-11e5-84c9-00000aacb35d&acdnat=1440130570_106bf60ce3c0229e

U2 - 10.1016/j.cct.2015.04.011

DO - 10.1016/j.cct.2015.04.011

M3 - Article

VL - 42

SP - 244

EP - 251

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

ER -